But for a large number of patients, the medications fall short, fail entirely, or come with side effects that make long-term use impossible
These effects lead to improved glycemic control and significant weight loss, making semaglutide useful in treating type 2 diabetes and obesity
Marbury TC, Flint A, Jacobsen JB, Karsbl JD
Efficacy and safety of aldosterone synthase inhibition with and without empagliflozin for chronic kidney disease: a randomised, controlled, phase 2 trial
The findings obtained from the SMART collaborative meta-analysis (SGLT2 Inhibitor Meta-Analysis Cardio-Renal Trialists), designed to evaluate the impact of SGLT2is on cardiovascular and renal outcomes based on the concomitant use or non-use of GLP1-RAs, included 12 controlled clinical trials with 73,238 participants, of whom 3065 (4.2%) received GLP1-RAs
Our Los Angeles registered nurses screen for these contraindications and coordinate with your physician when your history calls for it